Concepts in malignant haematology Flashcards

1
Q

what are the key actions of normal haemopoiesis

A
self-renewal (stem cells) 
proliferation 
differentiation 
maturation 
apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the non-lymphoid cells

A

erythrocytes
platelets
granulocytes
macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how do you identify normal non-lymphoid cells

A

Morphology

cell surface antigens (glycophorin A = red cells)

enzyme expression (myeloperoxidase = neutrophils)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how do you identify normal progenitors/ stem cells

A

cell surface antigens (immunophenotyping)

cell culture assays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what happens in malignant haemopoiesis

A

increased numbers of abnormal and dysfunctional cells

loss of normal activity

due to:

  • increased proliferation
  • lack of differentiation
  • lack of maturation
  • lack of apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is acute leukaemia

A

proliferation of abnormal progenitors with a block in differentiation/maturation

acute because cells proliferate quickly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the difference between acute myeloid leukemia and acute lymphoblastic leukaemia

A

in acute myeloid leukemia the myeloid progenitor cells rapidly proliferate

in acute lymphoblastic leukemia the lymphoid progenitors rapidly proliferate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is chronic myeloid leukemia

A

proliferation in abnormal myeloid progenitor cells

no block to differentiation/maturation (so normal mature cells are also produced)

therefore happens slower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

causes of haematological malignancy

A

Genetic
Epigenetic
environmental interaction

‘two hit hypothesis’

mutations in regulatory genes (driver mutations and passenger mutations)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what do ‘driver’ mutations in haemopoesis do

A

select ‘clones’

(a population of cells derived from one single parent cell which has a mutation shared by all the cells )

and causes them to divide more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the differences in normal and malignant haemopoeisis clones

A

normal haemopoeisis - ‘polyclonal’

malignant haemopoeisis - ‘monoclonal’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the two types of haematological malignancy based on anatomical site involved

A

leukaemia - blood

lymphoma - lymph noid involvement with lymphoid malignancy

myeloma - plasma cell malignancy in marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are histological features of aggressive leukemia/lymphoma

A

large cells with high nuclear-cytoplasmic ratio
prominent nucleoli
rapid proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is acute leukaemia

A

progressive clonal malignancy with maturation defects

‘blasts’ > 20% in either peripheral blood or bone marrow

loss of normal haemopoietic reserve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the two types of acute leukaemia

A

Acute myeloid Leukaemia (AML)

Acute lymphoblastic Leukaemia (ALL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is acute lymphoblastic leukaemia (ALL)

A

malignant disease of primitive lymphoid cells (lymphoblasts)

most common childhood cancer

17
Q

how does acute lymphoblastic leukaemia present

A

symptoms of marrow failure (anaemia, infections, bleeding)

Leukaemia effects - high count with obstruction of circulation, involvement of areas outside the marrow and blood (extra medullary)

bone pain

18
Q

what is acute myeloid leukaemia

A

malignant disease of primitive myeloid cells (myeloblasts)

19
Q

who gets acute myeloid leukaemia and how does it present

A

elderly (>60)

similar presentation to acute lymphoblastic leukaemia (marrow failure)

subgroups have characteristic presentation

20
Q

what investigations are done for acute leukaemia

A

Blood count and film

Coagulation screen

21
Q

what does the blood film look like in acute leukaemia (important)

A

Reduction in normal cells

Presence of abnormal cells (blasts with high nuclear:cytoplasmic ratio)

22
Q

what is seen on blood film in acute myeloid leukaemia

A

Auer Rod

> 20% blasts

23
Q

what investigation is required to definitely distinguish between acute myeloid leukaemia and acute lymphoblastic leukaemia

A

Immunophenotyping

shows the lineage associated proteins on the cells

24
Q

what are the curative treatments for acute lymphoblastic leukaemia

A

Multi-agent chemotherapy

can last up to 2-3 heats
different phases of treatment of varying intensity

targeted treatments in certain subsets

25
Q

what are the curative treatments of acute myeloid leukaemia

A

normally intensive multi-agent chemotherapy

2-4 cycles of chemo over 5-10 days (with 2-4 weeks recovery)

prolonged hospitalisation

targeted treatments in subsets

26
Q

what problems occur with bone marrow suppression

A

Anaemia

Neutropenia
-infections
gram-ve bacteria can cause life-threatening sepsis in neutropenic patients

Thrombocytopenia
-bleeding, purport, petechiae

27
Q

complications of chemotherapy for leukaemia

A
Nausea & vomiting 
hair loss 
liver, renal dysfunction 
tumour lysis syndrome 
infections (bacterial are common, sometimes fungal occurs) 
infertility 
cardiomyopathy 

others

28
Q

what is ‘remission’ of acute leukaemia

A

<5% marrow blasts with recovery of normal haemopoiesis

many patients see relapse

some patients die from treatment related toxicity

29
Q

cure rates for acute leukaemia

A

childhood ALL 85-90%
adult ALL 30-40%
Adult AML <60 40-50%
Adult AML >60 10% or less

30
Q

what leukaemia subtype is associated with disseminated intravascular coagulation

A

Acute promyelocytic leukaemia

sub type of acute myeloid leukaemia